ArticleBMC cancer2026
Developing a quality evaluation indicator system for lung cancer diagnosis and treatment: a modified Delphi method study.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo establish a quality evaluation index system for the diagnosis and treatment of lung cancer.
methodThe Donabedian health assessment model and Delphi method were used to construct an indicator system, and the Analytic Hierarchy Process was used to determine the weights of each level of indicators.
resultThe final indicator system constructed includes 3 primary indicators: structure, process and outcome, 15 secondary indicators, and 55 tertiary indicators. Structural indicators include staff, regulations, and facilities; Process indicators include diagnosis, multidisciplinary team (MDT), Neoadjuvant therapy, surgical treatment, adjuvant treatment, radiation therapy, systemic therapy, patient follow-up and patient-centered; Outcome indicators include effectiveness, safety and timeliness. Of the two rounds of Delphi experts consulting, the Expert Enthusiasm Coefficient were respectively 100.0% and 96.15%, the Expert Authority Coefficient were respectively 0.818 and 0.825, and Expert Coordination Coefficient was between 0.476 ~ 0.748.
conclusionThe quality evaluation indicator system of lung cancer has high credibility and can be used as a tool for evaluating the quality of lung cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.